Eric Laney - Masters Thesis Defense
March 28, 2018
Use of the Montreal Cognitive Assessment as an Early Indicator of Tumor Progression in Patients with Stage III and IV Gliomas
Wednesday, April 4
Spectrum Health, Conference Rm. 3001
25 Michigan St.
Prof. Deb Burg, BMS (chair); Dr. Wendy Sherman, Spectrum Health Neuro-oncology, Dr. Steven Pastyrnak, Helen DeVos Children’s Hospital